Newbridge Financial Services Group’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $866 | Buy |
2,867
+1,500
| +110% | +$453 | ﹤0.01% | 1214 |
|
|
2025
Q1 | $1.33K | Hold |
1,367
| – | – | ﹤0.01% | 924 |
|
|
2024
Q4 | $2.32K | Hold |
1,367
| – | – | ﹤0.01% | 952 |
|
|
2024
Q3 | $3.88K | Hold |
1,367
| – | – | ﹤0.01% | 524 |
|
|
2024
Q2 | $4.81K | Buy |
1,367
+682
| +100% | +$2.4K | ﹤0.01% | 853 |
|
|
2024
Q1 | $4.05K | Buy |
+685
| New | +$4.05K | ﹤0.01% | 915 |
|